RecruitingNot ApplicableNCT06175104

HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis

HeartGPS: A Longitudinal Randomized Controlled Trial Examining the Effects of a Prenatally-Delivered Psychological Intervention for Parents and Their Babies With Single Ventricle Congenital Heart Disease

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

50 participants

Start Date

Jul 14, 2025

Study Type

INTERVENTIONAL

Conditions

Neurodevelopmental Disorders Heart Defects, Congenital Depression, Postpartum Trauma, Psychological Anxiety in Pregnancy

Summary

Babies with single ventricle congenital heart disease (SVCHD) are often diagnosed during pregnancy. While prenatal diagnosis has important clinical benefits, it is often stressful and overwhelming for parents, and many express a need for psychological support. HeartGPS is a psychological intervention for parents who receive their baby's diagnosis of SVCHD during pregnancy. It includes 8 sessions with a psychologist, coupled with tailored educational resources, and a personalized care plan. The intervention focuses on fostering parent psychological adjustment and wellbeing, and supporting parents to bond with their baby in ways that feel right for them. Through this study, the investigators will learn if HeartGPS is useful and effective for parents and their babies when it is offered in addition to usual fetal cardiac care. The investigators will examine the effects of the HeartGPS intervention on parental anxiety, depression, and traumatic stress; fetal and infant brain development; parent-infant bonding; and infant neurobehavioral and neurodevelopmental outcomes. The investigators will also explore mechanisms associated with stress biology during pregnancy, infant brain development and neurodevelopmental outcomes, and parent and infant intervention effects.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (HeartGPS) is testing a psychological support program for pregnant people whose unborn baby has been diagnosed with a serious congenital heart defect (specifically single ventricle heart disease), to help them cope with the stress and prepare for their baby's care after birth. **You may be eligible if...** - You are pregnant and your fetus has been diagnosed with single ventricle congenital heart disease between 16 and 30 weeks of pregnancy - You are carrying a single baby (not twins or multiples) - You are planning to continue with the pregnancy - You are able to participate in English - You are 18 years or older **You may NOT be eligible if...** - Your baby has another condition that will also significantly affect brain development (like DiGeorge syndrome) - You have an untreated major psychiatric condition or substance use disorder - You have a moderate to severe intellectual disability - You are a surrogate carrying the baby for someone else Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHeartGPS

HeartGPS includes three key components: 1. Sessions with a psychologist trained to deliver the intervention using attachment-based and trauma-informed therapy techniques, coupled with mind-body skills. The intervention can be delivered in-person or via telehealth, in accordance with participants' preferences. 2. Educational resources, including a series of modules to complement the sessions and evidence-based tools to support psychological adjustment and coping, parent-infant bonding and attachment, and parent-clinician communication. 3. A personalized care plan, charting mental health care needs, goals, and preferences, with evidence-based strategies to support longer-term wellbeing.